Early results presented at a cancer research conference showed tumor shrinkage and slowed disease progression in patients who ...
Zai Lab Limited (NASDAQ:ZLAB) is one of the 10 Overlooked Growth Stocks to Buy Now. Zai Lab Limited (NASDAQ:ZLAB) is one of ...
Revolution Medicines, Inc. (Nasdaq: RVMD), a late-stage clinical oncology company developing targeted therapies for patients ...
MedPage Today on MSN
Early Lung Cancer Data Show Why FDA Approved HER2 Agent in First-Line
Zongertinib in phase I trial showed sustained efficacy in aggressive disease ...
First-line zongertinib showed antitumor activity in treatment-naive patients with advanced or metastatic HER2-mutant ...
Geminii, Inc., a company developing bioelectronic medicines, today announced that it will present new data at the AACR Annual Meeting 2026 in San Diego highlighting its non-small cell lung cancer ...
Leah Phillips, a Kentucky mom of three, said she was initially told her symptoms were due to a cold, allergies or anxiety ...
Researchers at Oregon State University have developed a technique for simultaneously treating lung cancer and a serious ...
The 84-year-old Navy veteran, whose real name is Kenny Jary, boasts over 4 million followers across social media platforms ...
Dr Christine Bestvina discusses EGFR treatment shifts, KRAS trial data, and expanding clinical trial access for community oncologists. Lung cancer treatment has undergone a remarkable transformation ...
The non-small cell lung cancer clinical trial analysis report delivers important insights into ongoing research of 120+ ...
In a preclinical study published in Cancer Research, researchers from the University of Texas MD Anderson Cancer Center have ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results